glp-1 treatment facial firmness loss medications mimic the effects of a naturally produced hormone that helps regulate appetite and digestion. "GLP-1 Face" describes the changes such as wrinkles and sagging skin that can accompany rapid GLP-1 medications (like semaglutide and

Furthermore, a systematic review of randomized controlled trials and observational studies also failed to identify an increased risk of aspiration pneumonia in GLP-1RA users, although an increased risk of retained gastric contents was evident (45)

Purpose-built for physicians GLP-1s tied to similar kidney cancer risk as SGLT2 inhibitors Key takeaways: Adults with type 2 diabetes had a similar risk for kidney cancer if they used a GLP-1 compared with an SGLT2 inhibitor

doi: 10.3389/fimmu.2024.1360065 46

Supplemental Figure S2, In the STRIDE and durvalumab monotherapy arms, grade 3 or higher imAEs occurred in 2 (0.5%) and 4 (1.0%) participants within 36 months after treatment initiation, and in 7 (1.8%) and 4 (1.0%) participants at least 6 months after treatment initiation, respectively